President and CEO of ARDEA BIOSCIENCES, INC. (RDEA, Financial) Barry D Quart sells 20,000 shares of RDEA on 08/09/2010 at an average price of $20.21 a share.
Ardea Biosciences, Inc. has a market cap of $469.9 million; its shares were traded at around $20.63 with and P/S ratio of 20.5.
Ardea Biosciences, Inc. has a market cap of $469.9 million; its shares were traded at around $20.63 with and P/S ratio of 20.5.
CEO Recent Trades:
- Sell: President and CEO Barry D Quart sold 25,000 shares of RDEA stock on 05/07/2010 at the average price of 21.2. Barry D Quart owns at least 41,515 shares after this. The price of the stock has decreased by 2.69% since.
Directors and Officers Recent Trades:
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 486,569 shares of RDEA stock on 04/06/2010 at the average price of 20. Brothers Life Sciences C Baker owns at least 3,680,512 shares after this. The price of the stock has increased by 3.15% since.
- Buy: Director, 10% Owner Capital (gp), Llc 14159 bought 13,431 shares of RDEA stock on 04/06/2010 at the average price of 20. Capital (gp), Llc 14159 owns at least 83,467 shares after this. The price of the stock has increased by 3.15% since.
- Sell: SVP, Regulatory & Dev Ops Kimberly Manhard sold 2,500 shares of RDEA stock on 07/28/2010 at the average price of 19.44. Kimberly Manhard owns at least 7,668 shares after this. The price of the stock has increased by 6.12% since.
- Sell: SVP & CBO Christopher W Krueger sold 3,000 shares of RDEA stock on 07/23/2010 at the average price of 18.54. Christopher W Krueger owns at least 933 shares after this. The price of the stock has increased by 11.27% since.
- Sell: Director Henry J Fuchs sold 2,000 shares of RDEA stock on 07/12/2010 at the average price of 19.95. Henry J Fuchs owns at least 10,416 shares after this. The price of the stock has increased by 3.41% since.
